SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,170.16 |
| Enterprise Value ($M) | 1,859.26 |
| Book Value ($M) | 660.00 |
| Book Value / Share | 9.66 |
| Price / Book | 3.29 |
| NCAV ($M) | 635.60 |
| NCAV / Share | 9.30 |
| Price / NCAV | 3.41 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.55 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.72 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.98 |
| Current Ratio | 4.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,280.20 |
| Assets | 1,304.60 |
| Liabilities | 644.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 78.50 |
| Operating Income | -401.50 |
| Net Income | -367.30 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -347.80 |
| Cash from Investing | 203.50 |
| Cash from Financing | 374.70 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rtw Investments, Lp | 6.20 | ||
| 13G | Price T Rowe Associates Inc /md/ | 5.60 | 61.96 | |
| 13G/A | EcoR1 Capital, LLC | 9.99 | 117.73 | |
| 13G/A | Avidity Partners Management LP | 4.40 | -39.69 | |
| 13G/A | Vanguard Group Inc | 7.13 | 8.84 | |
| 13G/A | BlackRock Inc. | 7.90 | 22.90 | |
| 13G/A | Fmr Llc | 3.97 | -52.32 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 135,222 | 576,325 | 23.46 | |
| 244,456 | 448,994 | 54.45 | |
| 200,018 | 299,135 | 66.87 | |
| 140,440 | 295,701 | 47.49 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ANNX – Annexon, Inc. | APLS – Apellis Pharmaceuticals, Inc. |
| ARQT – Arcutis Biotherapeutics, Inc. | ARWR – Arrowhead Pharmaceuticals, Inc. |
| ASMB – Assembly Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io